Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
Laureen Majed, Xavier Bresse, Nadia El Mouaddin, et al.
Vaccine (2020) Vol. 39, Iss. 2, pp. 438-446
Closed Access | Times Cited: 22

Showing 22 citing articles:

A global approach to improving penile cancer care
Marco Bandini, Mohamed E. Ahmed, Giuseppe Basile, et al.
Nature Reviews Urology (2021) Vol. 19, Iss. 4, pp. 231-239
Open Access | Times Cited: 52
Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018
Hannah G. Rosenblum, Rayleen M. Lewis, Julia W. Gargano, et al.
Annals of Internal Medicine (2022) Vol. 175, Iss. 7, pp. 918-926
Closed Access | Times Cited: 36
A two-sex model of human papillomavirus infection: Vaccination strategies and a case study
Shasha Gao, Maia Martcheva, Hongyu Miao, et al.
Journal of Theoretical Biology (2022) Vol. 536, pp. 111006-111006
Open Access | Times Cited: 12
Vaccination strategies in a pair formation model for human papillomavirus infection: An optimal control approach
Fernando Saldaña
Journal of Theoretical Biology (2024) Vol. 597, pp. 111994-111994
Closed Access | Times Cited: 2
Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent HPV vaccine in Hong Kong
Tak Hong Cheung, Sally Shuk Yee Cheng, Danny Hsu, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 5
Vaccinating women previously treated for human papillomavirus-related cervical precancerous lesions is highly cost-effective in China
Maosheng Zou, Hanting Liu, Huan Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium
Steven Simoens, André Bento‐Abreu, Barbara Merckx, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 9
Health impact and cost effectiveness of implementing gender-neutral HPV vaccination in Japan
Cody Palmer, Keisuke Tobe, Yusuke Negishi, et al.
Journal of Medical Economics (2023) Vol. 26, Iss. 1, pp. 1546-1554
Open Access | Times Cited: 3
On the Elimination of Infections Related to Oncogenic Human Papillomavirus: An Approach Using a Computational Network Model
Cintia Muñoz-Quiles, Javier Díez‐Domingo, L. Acedo, et al.
Viruses (2021) Vol. 13, Iss. 5, pp. 906-906
Open Access | Times Cited: 7
Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study
Faustine Dalon, Laureen Majed, Manon Belhassen, et al.
Vaccine (2021) Vol. 39, Iss. 36, pp. 5129-5137
Closed Access | Times Cited: 7
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
Kwame Owusu‐Edusei, Cody Palmer, Olga Ovcinnikova, et al.
Journal of health economics and outcomes research (2022) Vol. 9, Iss. 1, pp. 140-150
Open Access | Times Cited: 4
Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella
Kris Doggen, Albert Jan van Hoek, Jeroen Luyten
PharmacoEconomics (2023) Vol. 41, Iss. 5, pp. 481-497
Closed Access | Times Cited: 2
The impact of vaccination on human papillomavirus infection with disassortative geographical mixing: a two-patch modeling study
Shasha Gao, Maia Martcheva, Hongyu Miao, et al.
Journal of Mathematical Biology (2022) Vol. 84, Iss. 6
Closed Access | Times Cited: 3
Using a Dynamic Model to Estimate the Cost-Effectiveness of HPV Vaccination in Iran
Arnold Hagens, Albertus Constantijn Sloof, Roksana Janghorban
Vaccines (2024) Vol. 12, Iss. 4, pp. 438-438
Open Access
Attribute risk burden and prediction analysis of cervical cancer under different sociodemographic transitions worldwide from 1990 to 2034
Jie Hu, Yajie Wang, Zhengrong Cai
Research Square (Research Square) (2024)
Closed Access
Estimation of mid-and long-term benefits and hypothetical risk of Guillain-Barre syndrome after human papillomavirus vaccination among boys in France: A simulation study
Chi-Hong Duong, Judith E. Mueller, Pascale Tubert‐Bitter, et al.
Vaccine (2021) Vol. 40, Iss. 2, pp. 359-363
Open Access | Times Cited: 3
Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom
Kwame Owusu‐Edusei, Cody Palmer, Olga Ovcinnikova, et al.
Journal of health economics and outcomes research (2022) Vol. 9, Iss. 1
Open Access | Times Cited: 2
HPV vaccination should be extended to boys as part of the Hong Kong Childhood Immunisation Programme
Nicole TY Ngai, Wwt Lam, Radha Raghupathy
Hong Kong Medical Journal (2022) Vol. 28, Iss. 4, pp. 335-337
Open Access | Times Cited: 2
On the Elimination of Cancers Related to Oncogenic Human Papillomavirus: an Approach using a Computational Network Model
Cintia Muñoz-Quiles, Javier Díez‐Domingo, L. Acedo, et al.
(2021)
Open Access | Times Cited: 1
A two-sex model of human papillomavirus infection: Vaccination strategies and a case study
Shasha Gao, Maia Martcheva, Hongyu Miao, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
The Economic Evaluation of HPV Vaccination as a Prevention of Non-Cervical Cancer Using Modelling Approaches: A Systematic Review
Nur Hidayati, Dwi Endarti, Didik Setiawan
BIO Web of Conferences (2023) Vol. 75, pp. 05018-05018
Open Access
Gender-neutral HPV vaccination cost effective versus girls-only

PharmacoEconomics & Outcomes News (2020) Vol. 868, Iss. 1, pp. 17-17
Closed Access
Page 1

Scroll to top